News

Immuneering signs supply deal with Lilly to test atebimetinib plus olomorasib

Immuneering (IMRX) partners with Eli Lilly to test atebimetinib + olomorasib in a phase 2 trial targeting KRAS G12c-mutant ...

Immuneering Announces Clinical Supply Agreement with Lilly to Evaluate Atebimetinib in Combination with Olomorasib

Immuneering to evaluate atebimetinib in combination with olomorasib in planned Phase 2 trial in patients with advanced non-small cell lung cancer – CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ...
Plasteurope.com4h

Recycling JV Reks to be discontinued / Future of plant in Kosovo uncertain

© 2001-2025 Plasteurope.com | Imprint | Privacy | Cookie settings ...